NCT02923206 - Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

August 20, 2024

Study Completion Date

July 16, 2025

Conditions

Preeclampsia

Interventions

DEVICE

TheraSorb sFlt-1 adsorber

Removal of excessive sFlt-1 from the plasma of subjects/ patients with therapeutic apheresis.

Trial Locations (4)

Universitätsklinikum Köln, Cologne

Universitätsklinikum Leipzig, Leipzig

Cambridge Clinical Trials Unit, Addenbrooke's Hospital, Cambridge

Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford